You just read:

Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds

News provided by

Allergan plc

09 Jan, 2017, 08:30 ET